A carregar...

Gemcitabine for the treatment of advanced nonsmall cell lung cancer

Gemcitabine is a pyrimidine nucleoside antimetabolite agent which is active in several human malignancies, including nonsmall cell lung cancer (NSCLC). Because of its acceptable toxicity profile, with myelosuppression being the most common adverse event, gemcitabine can be safely combined with a num...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Toschi, Luca, Cappuzzo, Federico
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886326/
https://ncbi.nlm.nih.gov/pubmed/20616908
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!